Company / Cost of Revenue
Regenerative Medical Technology Group Inc. Cost of Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$2.3M
FY2025
5-year range
$287.8K / $2.3M
FY2021-FY2025
Trend
+78.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 5 consecutive years, from $43,954 in FY2020 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +120.5%.
Increased from $734,285 to $2M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +51.9%
- 5-Year CAGR
- +120.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +120.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 78.3% year-over-year.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | +78.3% |
| FY2024 | $1.3M | +74.9% |
| FY2023 | $734.3K | +12.4% |
| FY2022 | $653.3K | +127.0% |
| FY2021 | $287.8K | +554.7% |
| FY2020 | $44.0K | -20.8% |
| FY2019 | $55.5K | -18.7% |
| FY2018 | $68.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026